Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Director | June 16, 2023 | June 21, 2023 |
| Voyager Therapeutics, Inc.VYGR · Entity 6271 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date June 16, 2023 · Filed June 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,708 |
Reported balance
After 2023-06-16 transaction · row 1
1 source rowRow 1 · 2023-06-16 · Grant · Acquired 18,844 · Balance 23,708 F1: The reported securities are represented by restricted stock units which shall vest on June 16, 2024. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $7.96 · Expires 2033-06-16 | Direct | 29,136 |
Reported balance
After 2023-06-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-16 · Grant · Acquired 29,136 · Balance 29,136 F2: 1/12th of the shares subject to the option shall vest on July 16, 2023 and the shares subject to the option shall vest monthly thereafter through June 16, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units which shall vest on June 16, 2024.
F2: 1/12th of the shares subject to the option shall vest on July 16, 2023 and the shares subject to the option shall vest monthly thereafter through June 16, 2024.
Voyager Therapeutics, Inc.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.43 · Expires 2036-06-09 | Direct | Not disclosed |
Reported balance
After 2026-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 30,000 · Balance Not disclosed F1: This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 20:01 UTC | Voyager Therapeutics, Inc. VYGR · Entity 6271 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001104659-26-072919 · tm2617547-2_4seq1.xml · derivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 30,000 shares Expires 2036-06-09 F1 · derivative.exercise_date: This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 00:58 UTC | Voyager Therapeutics, Inc. VYGR · Entity 6271 | GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $3.28 | $0.00 |
DisclosureSEC source: 0001104659-25-056559 · tm2517191-1_4seq1.xml · derivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-06-03 F1 · derivative.exercise_date: This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:15 UTC | Voyager Therapeutics, Inc. VYGR · Entity 6271 | GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $8.70 | $0.00 |
DisclosureSEC source: 0001104659-24-069650 · tm2416702-1_4seq1.xml · derivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 22:50 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock · Derivative | 29,136 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001217234-23-000124 · wf-form4_168738782032025.xml · derivative · entry 2 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,136 Underlying: Common Stock · 29,136 shares Expires 2033-06-16 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2023 and the shares subject to the option shall vest monthly thereafter through June 16, 2024. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 22:50 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 18,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-23-000124 · wf-form4_168738782032025.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,708 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2024. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:37 UTC | Voyager Therapeutics, Inc. VYGR · Entity 6271 | GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $12.57 | $0.00 |
DisclosureSEC source: 0001104659-23-068924 · tm2317994-4_4seq1.xml · derivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:55 UTC | Voyager Therapeutics, Inc. VYGR · Entity 6271 | GrantStock Option (Right to Buy) · Derivative | 44,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001104659-23-000894 · tm231578-2_4seq1.xml · derivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2033-01-01 F1 · derivative.exercise_date: This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. The option vests over four years, with 1/16th of the shares of common stock underlying the option vesting upon the three-month anniversary of the Vesting Commencement Date and an additional 1/16th of the shares of common stock underlying the option vesting at the end of each successive three-month period thereafter, subject to the Reporting Person's continued service as a director. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 01:50 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,521 | $24.81 | $62,546.01 |
DisclosureSEC source: 0001217234-22-000157 · wf-form4_166026900427264.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:05 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock · Derivative | 7,606 | $0.00 Strike: $20.56 | $0.00 |
DisclosureSEC source: 0001217234-22-000119 · wf-form4_165584552442045.xml · derivative · entry 2 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606 Underlying: Common Stock · 7,606 shares Expires 2032-06-16 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2022 and the shares subject to the option shall vest monthly thereafter through June 16, 2023. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:05 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-22-000119 · wf-form4_165584552442045.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,385 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2023. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:21 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 5,179 | $23.01 | $119,168.79 |
DisclosureSEC source: 0001217234-22-000099 · wf-form4_165247681898288.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,522 Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:15 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,393 | $34.56 | $48,146.12 |
DisclosureSEC source: 0001217234-22-000064 · wf-form4_164703690329040.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,701 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.56 to $34.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 22, 2021 00:02 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 1,812 | $0.00 Strike: $88.70 | $0.00 |
DisclosureSEC source: 0001217234-21-000146 · wf-form4_162432016232144.xml · derivative · entry 2 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,812 Underlying: Common Stock · 1,812 shares Expires 2031-06-16 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2021 and the shares subject to the option shall vest monthly thereafter through June 16, 2022. Read SEC document |
| June 16, 2021 Filed Jun 22, 2021 00:02 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-21-000146 · wf-form4_162432016232144.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,094 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2022. Read SEC document |
| June 18, 2020 Filed Jun 20, 2020 01:20 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 4,978 | $31.35 Strike: $31.35 | $156,060.30 |
DisclosureSEC source: 0001217234-20-000102 · wf-form4_159261598754484.xml · derivative · entry 2 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,978 Underlying: Common Stock · 4,978 shares Expires 2030-06-18 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 18, 2020 and the shares subject to the option shall vest monthly thereafter through June 18, 2021. Read SEC document |
| June 18, 2020 Filed Jun 20, 2020 01:20 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 3,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-20-000102 · wf-form4_159261598754484.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,967 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 18, 2021. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 00:43 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 326 | $0.00 | $0.00 |
DisclosureSEC source: 0001780354-20-000002 · wf-form4_157809856545889.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,777 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 21:23 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-024747 · doc4.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:17 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 6,569 | $0.00 Strike: $35.87 | $0.00 |
DisclosureSEC source: 0000899243-19-019153 · doc4.xml · derivative · entry 2 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 Underlying: Common Stock · 6,569 shares Expires 2029-07-01 F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on August 1, 2019 and 1/36th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:17 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 4,181 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-019153 · doc4.xml · nonDerivative · entry 1 Colon Grace · CIK 0001780354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,181 F1 · shares: The reported securities are represented by restricted stock units 1/3rd of which shall vest on July 1, 2020 and 1/3rd of which shall vest on each anniversary thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.